Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-08 5:52:16 am | MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q4 2023 | InvestorPlace |
| 2024-03-07 1:30:0 pm | Merrimack Reports Full Year 2023 Financial Results | Business Wire |
| 2024-03-04 4:3:41 am | Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company | Simply Wall St. |
| 2024-02-13 1:18:0 pm | Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | Business Wire |
| 2023-12-10 5:20:12 am | We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow | Simply Wall St. |
Please consider a small donation if you think this website provides you with relevant information